谢良志

All filings by 谢良志 on record concern 神州细胞, in the capacity of board member. We count 6 filings; the first trade dates from 24 June 2022 and the latest from 4 July 2022.

On the market, this insider has only ever bought: 6 purchases, €2.3M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

In size, the median ticket on the buying side is €432k. The 6 purchases reviewed show no overlap with other insiders buying the same stock within a month. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -13.0%. These figures describe past trades and do not predict future prices.

On 4 July 2022 came the latest disclosure, an open-market purchase for €482k in 神州细胞. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.